Cargando…
The effectiveness of a modified Gui Zhi Fu Ling Wan formulation (Gynoclear™) for the treatment of endometriosis: a study protocol for a placebo-controlled, double-blind, randomised controlled trial
BACKGROUND: Endometriosis is the presence of tissue similar to that of the endometrium outside the uterine cavity and is the most common cause of chronic pelvic pain. Current non-surgical treatments such as non-steroidal anti-inflammatories, oral contraceptive pills and hormonal treatments have limi...
Autores principales: | Armour, Mike, Al-Dabbas, Mahmoud A., Ee, Carolyn, Smith, Caroline A., Ussher, Jane, Arentz, Susan, Lawson, Kenny, Abbott, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058744/ https://www.ncbi.nlm.nih.gov/pubmed/33883001 http://dx.doi.org/10.1186/s13063-021-05265-x |
Ejemplares similares
-
Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) Ameliorates Human Uterine Myomas via Apoptosis
por: Lee, So Min, et al.
Publicado: (2019) -
Exploring the mechanisms of Gui Zhi Fu Ling Wan on varicocele via network pharmacology and molecular docking
por: Wang, Ruipeng, et al.
Publicado: (2022) -
Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches
por: Wang, Qiao, et al.
Publicado: (2019) -
Understanding the Role of Gui-Zhi-Fu-Ling-Capsules (Chinese Medicine) for Treatment of Endometriosis in the Rat Model: Using NMR Based Metabolomics
por: Zhou, Jue, et al.
Publicado: (2018) -
Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis
por: Nozaki, Kazuya, et al.
Publicado: (2006)